Truncated PAP2 and methods of making and using same
AssigneeThe Research Foundation of State University of New York
InventorsMartin H. Bluth, Michael Zenilman
Life of this patent
Estimating the term…
Abstract
A method of treating pancreatitis is provided, including the steps of: providing a mammal having pancreatitis; and administering a therapeutically effective amount of a truncated N-terminal PAP2; and making of an antibody specifically directed to detect PAP2.
Claims10
A truncated pancreatitis associated protein of the sequence listing
- (SEQ ID NO:
- 1)
- LVTTLKSWFQADLACQKRPSGHLVSILSGGEASFVSSLVTGRVNNNQDIW
- IWLHDPTMGQQPNGGGWEWSNSDVLNYLNWDGDPSSTVNRGNCGSLTATS
- EFLKWGDHHCDVELPFVCKFKQ.
A peptide sequence usable to make anti-PAP2 antibody of the sequence TMGQQPNGGGWEWSNSDVLNYLNWDGDPSST (SEQ ID. NO. 25).
A method of treating pancreatitis, comprising:
- providing a mammal having pancreatitis;
- and
- administering a therapeutically effective amount of truncated pancreatitis associated protein of the sequence listing
- (SEQ ID NO:
- 1)
- LVTTLKSWFQADLACQKRPSGHLVSILSGGEASFVSSLVTGRVNNNQDIWI
- WLHDPTMGQQPNGGGWEWSNSDVLNYLNWDGDPSSTVNRGNCGSLTATSEF
- LKWGDHHCDVELPFVCKFKQ.
A method of providing an immunomodulatory effect in a mammal with pancreatitis, comprising:
- administering to the mammal in need thereof a therapeutically effective amount of a truncated pancreatitis associated protein of the sequence listing
- (SEQ ID NO:
- 1)
- LVTTLKSWFQADLACQKRPSGHLVSILSGGEASFVSSLVTGRVNNNQDIWI
- WLHDPTMGQQPNGGGWEWSNSDVLNYLNWDGDPSSTVNRGNCGSLTATSEF
- LKWGDHHCDVELPFVCKFKQ.
A method of making recombinant truncated pancreatitis-associated protein of the sequence listing
- (SEQ ID NO:
- 1)
- LVTTLKSWFQADLACQKRPSGHLVSILSGGEASFVSSLVTGRVNNNQDIWI
- WLHDPTMGQQPNGGGWEWSNSDVLNYLNWDGDPSSTVNRGNCGSLTATSEF
- LKWGDHHCDVELPFVCKFKQ,
- comprising the steps of:
- Inserting a nucleic acid encoding SEQ ID NO:1 in-frame into a pET24a bacterial expression vector;
- growing a plurality of positive clones transformed into a plurality of bacterium to a density in a medium;
- centrifuging and resuspending the bacterium in a resuspension buffer;
- sonicating the bacterium with a protease inhibitor to lyse the cells;
- centrifuging and washing the bacterial cell lysate pellet in a first buffer;
- solubilizing said bacterial cell lysate pellet in a second buffer containing 6 M urea.
Dependencies are inferred from the claim text.